title: Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations.
authors: 1 Department of Clinical Pharmacology and Toxicology, CHU Nancy, Nancy, France. 2 Université de Lorraine, UMR 7365 CNRS-UL, IMoPA, Vandœuvre-lès-Nancy, France. 3 Pharmacovigilance Center of Lorraine, CHU Nancy, Nancy, France. 4 Department of Biochemistry, CHU Strasbourg, Strasbourg, France. 5 Department of Hepatology and Gastroenterology, CHU Nancy, Vandoeuvre-lès-Nancy, France.
authors: Elise
authors: E
authors: Pape
authors: Julien
authors: J
authors: Scala-Bertola
authors: Nadine
authors: N
authors: Petitpain
authors: Jean-Yves
authors: JY
authors: Jouzeau
authors: Sophie
authors: S
authors: Charrois-Sciaudeau
authors: Véronique
authors: V
authors: Kemmel
authors: Hélène
authors: H
authors: Barraud
authors: Nicolas
authors: N
authors: Gambier
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D016174:Hepacivirus / Q000187:drug effects*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008103:Liver Cirrhosis / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D009842:Oligopeptides / Q000627:therapeutic use*; D016559:Tacrolimus / Q000008:administration & dosage*
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D009842:Oligopeptides; D016559:Tacrolimus